Abstract:A novel computational method called SMNPLS (Sparse Multi‐Network Regularized Partial Least Squares) is developed to extract modularized patterns from joint matrices of splicing factors expression and PSI (percent spliced‐in) values of alternative splicing events and uncovered the global landscape of splicing dysregulations by altered splicing factors expressions across 31 TCGA solid tumors. Splicing dysregulation arising from spliceosomal mutations contributes to disease progression and treatment resistance, mostly in hematologic malignancy. Whereas spliceosomal mutations are less common in solid tumors, splicing disorders are pervasive and proven to promote tumorigenesis. However, there is a lack of systematic understanding of the overall splicing dysregulation patterns and how widespread different patterns occur within or across solid tumor lineage. To address these questions, a computational method called SMNPLS (Sparse Multi‐Network Regularized Partial Least Squares) is developed to uncover the pan‐cancer splicing dysregulation landscape by extracting joint modular patterns from paired matrices of splicing factors (SFs) expressions and alternative splicing events (ASEs). Six unique patterns illustrated by ASE‐SF co‐modules are summarized, which involve 1,570 ASEs and altered expression of 170 SFs, covering 40% of TCGA solid tumors. Cross‐cancer commonalities of splicing dysregulation are observed among digestive system neoplasms, renal‐associated tumors, and urogenital tumors. By contrast, brain tumors demonstrate a distinct splicing pattern with the highest ASE‐SF correlation. In addition, some new splicing regulatory relationships are identified that are potentially oncogenic. Overall, the study characterizes the full spectrum of splicing dysregulation patterns, indicating the similarity and specificity of splicing‐derived pathogenesis across 31 human solid tumors.

Splicing factors: Insights into their regulatory network in alternative splicing in cancer

Alternative splicing and cancer: a systematic review

The interplay between non-coding RNAs and alternative splicing: from regulatory mechanism to therapeutic implications in cancer

Splicing factor-mediated regulation patterns reveals biological characteristics and aid in predicting prognosis in acute myeloid leukemia

Study of prognostic splicing factors in cancer using machine learning approaches

A pan-cancer analysis of alternative splicing of splicing factors in 6904 patients

The role of alternative splicing in human cancer progression.

Targeting splicing factors for cancer therapy

SRSF6-regulated Alternative Splicing That Promotes Tumour Progression Offers a Therapy Target for Colorectal Cancer

Impacts and mechanisms of alternative mRNA splicing in cancer metabolism, immune response, and therapeutics

Splicing Dysregulation in Cancer: from Mechanistic Understanding to a New Class of Therapeutic Targets

Integrated Multi-Omics Analysis of the Clinical Relevance and Potential Regulatory Mechanisms of Splicing Factors in Hepatocellular Carcinoma.

Overcoming cancer drug-resistance calls for novel strategies targeting abnormal alternative splicing

Genome-wide identification of pan-cancer common and cancer-specific alternative splicing events in 9 types of cancer

Alternative Splicing in Myeloid Malignancies

Systematic Characterization of Splicing Dysregulation in Pan Solid Tumor Transcriptome

Significance of Alternative Splicing in Cancer Cells.

Correlations Between the Characteristics of Alternative Splicing Events, Prognosis, and the Immune Microenvironment in Breast Cancer

Analysis of Colorectal Cancer-Associated Alternative Splicing Based on Transcriptome.

Alternative splicing of mRNA in colorectal cancer: new strategies for tumor diagnosis and treatment

The crosstalk between alternative splicing and circular RNA in cancer: pathogenic insights and therapeutic implications